Results 201 to 210 of about 212,593 (281)

Serum Amyloid A (SAA) and Its Interaction with High-Density Lipoprotein Cholesterol (HDL-C): A Comprehensive Review. [PDF]

Int J Mol Sci
Moissl-Blanke AP, Delgado GE, Krämer BK, Siekmeier R, Duerschmied D, März W, Kleber ME.   +6 more
europepmc   +1 more source

Exploring the Anti‐Diabetic Potential of Anthocyanins: From Biochemical Pathways to Human Trials

Chronic Diseases and Translational Medicine, EarlyView.
ABSTRACT Diabetes mellitus (DM) is a global health challenge with increasing prevalence rates, particularly in low‐ and middle‐income countries. Anthocyanins (ACs) are potential bioactive compounds found in various fruits and vegetables, attracting the attention of researchers due to their possible role in managing diabetes and its complications ...
Lakshay Panchal, Sangeeta Yadav, Akash Kumar, Tanbeer Kaur, Yashna Bawa, Sarvesh Rustagi, Rahul Mehra   +6 more
wiley   +1 more source

Post-Translational Modifications of Lipoproteins: Emerging Players Linking Inflammation and Cardiovascular Disease in Rheumatoid Arthritis-A Narrative Review. [PDF]

Int J Mol Sci
Xu C, Rodríguez-Carrio J, Xie Y, Hu F, Chong WM, Hou HW, Dalan R, Leong KP.   +7 more
europepmc   +1 more source

Role of mycobacteria-induced monocyte/macrophage apoptosis in the pathogenesis of human tuberculosis [PDF]

, 2005
BOCCHINO, MARIALUISA, BRUNETTI E., COLIZZI V, GALATI D, SANDUZZI ZAMPARELLI, ALESSANDRO   +4 more
core  

Prognostic Implication of CYP2C19 Genotype According to Clinical Risk Stratification After Drug‐Eluting Stent Implantation

Clinical Pharmacology &Therapeutics, EarlyView.
From the nationwide multicenter consortium, 8,163 patients undergoing drug‐eluting stent implantation were classified according to the presence of the CYP2C19 loss‐of‐function (LoF) allele: rapid or normal metabolizers (RMs/NMs) vs. intermediate or poor metabolizers (IMs/PMs), and clinical risk was stratified using the CHADS‐P2A2RC and TRS 2°P scores ...
Hyun Woong Park, Jae‐Hwan Lee, Jin‐Ok Jeong, Diana A. Gorog, Udaya S. Tantry, Byeong‐Keuk Kim, Hyung Joon Joo, Kiyuk Chang, Jin‐Yong Hwang, Young Bin Song, Sung Gyun Ahn, Jung‐Won Suh, Woong Gil Choi, Jung Rae Cho, Jeehoon Kang, Sang Yeub Lee, Hyo‐Soo Kim, Moo Hyun Kim, Do‐Sun Lim, Eun‐Seok Shin, Paul A. Gurbel, Young‐Hoon Jeong, on behalf of the PTRG‐DES Consortium Investigators   +22 more
wiley   +1 more source

The molecular interplay among gut dysbiosis, adipose tissue, and metabolite-derived damage-associated molecular patterns in metainflammation and atherogenesis. [PDF]

Front Immunol
González-Hermosillo LM, Ávila-Soto KI, Méndez-García LA, Cérbulo-Vázquez A, Esquivel-Velázquez M, Bueno-Hernández N, Fonseca-Sánchez MÁ, Escobedo G.   +7 more
europepmc   +1 more source

Navigating the Genetic Risk of Chemotherapy‐Induced Hearing Loss in the Stria Vascularis

Clinical Pharmacology &Therapeutics, EarlyView.
Cisplatin is a chemotherapy drug that causes permanent hearing loss by damaging a critical tissue lining the inner ear, called the stria vascularis (SV). Currently, the molecular mechanisms of SV damage are largely unknown and the incidence of ototoxicity in patients cannot be reliably predicted.
Tara Lazetic, Deanne Nixie R. Miao, Britt I. Drögemöller, Alain Dabdoub, Julia M. Abitbol   +4 more
wiley   +1 more source

Low density lipoprotein receptor-related protein 8: a critical receptor for tick-borne encephalitis virus entry. [PDF]

Signal Transduct Target Ther
Jiao P, Du L, Zeng Y.
europepmc   +1 more source

Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statins. [PDF]

Prostate Int, 2016
Furuya Y, Sekine Y, Kato H, Miyazawa Y, Koike H, Suzuki K.   +5 more
europepmc   +1 more source

Low-Density Lipoprotein Receptor [PDF]

, 2020
openaire   +1 more source